Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
GABAB-Receptor Agonist-Based Immunotherapy for Type 1 Diabetes in NOD Mice.
Journal: Biomedicines
Published: December 07, 2020
Homotaurine Treatment Enhances CD4+ and CD8+ Regulatory T Cell Responses and Synergizes with Low-Dose Anti-CD3 to Enhance Diabetes Remission in Type 1 Diabetic Mice.
Journal: ImmunoHorizons
Published: March 11, 2019
Showing 1-2 of 2
Last Updated: 09/26/2026